- call +1-201-465-4211
- email sales@mrinsights.biz
Sexually transmitted diseases (STDs) are infections that are passed from one person to another through sexual contact. The causes of STDs are bacteria, parasites, yeast, and viruses.
Scope of the Report:
Sexually Transmitted Disease is growing at a faster pace owing to the rising incidences of unprotected sex, lack of awareness and so forth. The rising number of patients suffering from STD includes people from age group of 15 years to 24 years.
The global Sexually Transmitted Disease (STD) Diagnosis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Sexually Transmitted Disease (STD) Diagnosis.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Sexually Transmitted Disease (STD) Diagnosis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Sexually Transmitted Disease (STD) Diagnosis market by product type and applications/end industries.
Market Segment by Companies, this report covers
Abbott
Roche
Thermo Fisher Scientific
Aposcience
BCR Diagnostics
BD Medical
Biocartis
BioMérieux
Bio-Rad
Cepheid
Danaher
DiaSorin
Quidel
GenMark Diagnostics
Hologic
OraSure Technologies
Qualigen
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Chlamydia testing
Syphilis testing
Gonorrhoea testing
Herpes simplex virus testing
Human papilloma virus testing
Human immunodeficiency virus testing
Market Segment by Applications, can be divided into
Government organizations
Hospitals
Diagnostic clinics
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Sexually Transmitted Disease (STD) Diagnosis Market Overview
1.1 Product Overview and Scope of Sexually Transmitted Disease (STD) Diagnosis
1.2 Classification of Sexually Transmitted Disease (STD) Diagnosis by Types
1.2.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Comparison by Types (2017-2023)
1.2.2 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Types in 2017
1.2.3 Chlamydia testing
1.2.4 Syphilis testing
1.2.5 Gonorrhoea testing
1.2.6 Herpes simplex virus testing
1.2.7 Human papilloma virus testing
1.2.8 Human immunodeficiency virus testing
1.3 Global Sexually Transmitted Disease (STD) Diagnosis Market by Application
1.3.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Government organizations
1.3.3 Hospitals
1.3.4 Diagnostic clinics
1.4 Global Sexually Transmitted Disease (STD) Diagnosis Market by Regions
1.4.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Sexually Transmitted Disease (STD) Diagnosis Status and Prospect (2013-2023)
1.5 Global Market Size of Sexually Transmitted Disease (STD) Diagnosis (2013-2023)
2 Manufacturers Profiles
2.1 Abbott
2.1.1 Business Overview
2.1.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Abbott Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche
2.2.1 Business Overview
2.2.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.3 Thermo Fisher Scientific
2.3.1 Business Overview
2.3.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Thermo Fisher Scientific Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.4 Aposcience
2.4.1 Business Overview
2.4.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Aposcience Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.5 BCR Diagnostics
2.5.1 Business Overview
2.5.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BCR Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.6 BD Medical
2.6.1 Business Overview
2.6.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 BD Medical Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.7 Biocartis
2.7.1 Business Overview
2.7.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Biocartis Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.8 BioMérieux
2.8.1 Business Overview
2.8.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 BioMérieux Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.9 Bio-Rad
2.9.1 Business Overview
2.9.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Bio-Rad Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.10 Cepheid
2.10.1 Business Overview
2.10.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Cepheid Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.11 Danaher
2.11.1 Business Overview
2.11.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Danaher Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.12 DiaSorin
2.12.1 Business Overview
2.12.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 DiaSorin Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.13 Quidel
2.13.1 Business Overview
2.13.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Quidel Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.14 GenMark Diagnostics
2.14.1 Business Overview
2.14.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 GenMark Diagnostics Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.15 Hologic
2.15.1 Business Overview
2.15.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Hologic Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.16 OraSure Technologies
2.16.1 Business Overview
2.16.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 OraSure Technologies Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
2.17 Qualigen
2.17.1 Business Overview
2.17.2 Sexually Transmitted Disease (STD) Diagnosis Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Qualigen Sexually Transmitted Disease (STD) Diagnosis Revenue, Gross Margin and Market Share (2016-2017)
3 Global Sexually Transmitted Disease (STD) Diagnosis Market Competition, by Players
3.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Sexually Transmitted Disease (STD) Diagnosis Players Market Share
3.2.2 Top 10 Sexually Transmitted Disease (STD) Diagnosis Players Market Share
3.3 Market Competition Trend
4 Global Sexually Transmitted Disease (STD) Diagnosis Market Size by Regions
4.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Market Share by Regions
4.2 North America Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
4.3 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
4.5 South America Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
5 North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
5.1 North America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2013-2018)
5.2 USA Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
5.3 Canada Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
5.4 Mexico Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
6 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
6.1 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2013-2018)
6.2 Germany Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
6.3 UK Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
6.4 France Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
6.5 Russia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
6.6 Italy Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
7.1 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2013-2018)
7.2 China Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
7.3 Japan Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
7.4 Korea Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
7.5 India Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
8 South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries
8.1 South America Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2013-2018)
8.2 Brazil Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
8.3 Argentina Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
8.4 Colombia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Sexually Transmitted Disease (STD) Diagnosis by Countries
9.1 Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue by Countries (2013-2018)
9.2 Saudi Arabia Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
9.3 UAE Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
9.4 Egypt Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
9.5 Nigeria Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
9.6 South Africa Sexually Transmitted Disease (STD) Diagnosis Revenue and Growth Rate (2013-2018)
10 Global Sexually Transmitted Disease (STD) Diagnosis Market Segment by Type
10.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue and Market Share by Type (2013-2018)
10.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Type (2018-2023)
10.3 Chlamydia testing Revenue Growth Rate (2013-2023)
10.4 Syphilis testing Revenue Growth Rate (2013-2023)
10.5 Gonorrhoea testing Revenue Growth Rate (2013-2023)
10.6 Herpes simplex virus testing Revenue Growth Rate (2013-2023)
10.7 Human papilloma virus testing Revenue Growth Rate (2013-2023)
10.8 Human immunodeficiency virus testing Revenue Growth Rate (2013-2023)
11 Global Sexually Transmitted Disease (STD) Diagnosis Market Segment by Application
11.1 Global Sexually Transmitted Disease (STD) Diagnosis Revenue Market Share by Application (2013-2018)
11.2 Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Application (2018-2023)
11.3 Government organizations Revenue Growth (2013-2018)
11.4 Hospitals Revenue Growth (2013-2018)
11.5 Diagnostic clinics Revenue Growth (2013-2018)
12 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast (2018-2023)
12.1 Global Sexually Transmitted Disease (STD) Diagnosis Market Size Forecast (2018-2023)
12.2 Global Sexually Transmitted Disease (STD) Diagnosis Market Forecast by Regions (2018-2023)
12.3 North America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2018-2023)
12.4 Europe Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2018-2023)
12.6 South America Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Sexually Transmitted Disease (STD) Diagnosis Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Sexually Transmitted Disease (STD) Diagnosis Picture
Table Product Specifications of Sexually Transmitted Disease (STD) Diagnosis
Table Global Sexually Transmitted D
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
